Awakn Life Sciences (Awakn Life Sciences) Scaled Net Operating Assets : -1.81 (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Awakn Life Sciences's operating assets for the quarter that ended in Jan. 2024 was $0.10 Mil. Awakn Life Sciences's operating liabilities for the quarter that ended in Jan. 2024 was $1.55 Mil. Awakn Life Sciences's Total Assets for the quarter that ended in Oct. 2023 was $0.80 Mil. Therefore, Awakn Life Sciences's scaled net operating assets (SNOA) for the quarter that ended in Jan. 2024 was -1.81.

Awakn Life Sciences Scaled Net Operating Assets Historical Data

The historical data trend for Awakn Life Sciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Scaled Net Operating Assets Chart

Awakn Life Sciences Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Scaled Net Operating Assets

0.28

3.92

0.23

-0.44

Awakn Life Sciences Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Scaled Net Operating Assets	Get a 7-Day Free Trial								0.30	0.31	-0.36	-1.62	-1.81

Competitive Comparison of Awakn Life Sciences's Scaled Net Operating Assets

For the Biotechnology subindustry, Awakn Life Sciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Awakn Life Sciences's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's Scaled Net Operating Assets falls into.

Awakn Life Sciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Awakn Life Sciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jan. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jan. 2024 )
=	(Operating Assets (A: Jan. 2024 )	-	Operating Liabilities (A: Jan. 2024 ))	/	Total Assets (A: Jan. 2023 )
=	(0.102	-	1.545)	/	3.274
=	-0.44

where

	Operating Assets		(A: Jan. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.405	-	0.303
=	0.102

	Operating Liabilities		(A: Jan. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.545	-	0	-	0
=	1.545

Awakn Life Sciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jan. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jan. 2024 )
=	(Operating Assets (Q: Jan. 2024 )	-	Operating Liabilities (Q: Jan. 2024 ))	/	Total Assets (Q: Oct. 2023 )
=	(0.102	-	1.545)	/	0.796
=	-1.81

where

	Operating Assets		(Q: Jan. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.405	-	0.303
=	0.102

	Operating Liabilities		(Q: Jan. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.545	-	0	-	0
=	1.545

Awakn Life Sciences Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Awakn Life Sciences (Awakn Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

954:Germany AWKN:Canada

Address

301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2

Website

https://www.awaknlifesciences.com

Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines

From GuruFocus

KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th

By PRNewswire PRNewswire • 10-11-2021

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By GuruFocusNews GuruFocusNews • 07-01-2022

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By PurpleRose PurpleRose • 07-11-2022

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By GuruFocusNews GuruFocusNews • 06-21-2022